Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion type Assertion NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_head.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion description "[In conclusion, to the best of our knowledge this study was the first to show that miR-429 is involved in the oncogenesis of prostate cancer and thus may be a novel prognostic biomarker in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_provenance.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion evidence source_evidence_literature NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_provenance.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion SIO_000772 25351256 NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_provenance.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion wasDerivedFrom befree-2016 NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_provenance.
- NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_assertion wasGeneratedBy ECO_0000203 NP1233206.RA00Y-NSgkAL3IxI-NfT1_CcA8Bt4tbI16i_iginF9u6E130_provenance.